Offline dengan aplikasi Player FM !
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
Manage episode 438235756 series 3389426
touchCONGRESS for touchONCOLOGY
Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Dr McDonald
- Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below
Clinical themes
- How does ITP impact the patient and their quality of life?
- What are the latest data that inform the use of current treatments for chronic ITP?
- What data are there for emerging chronic ITP treatments and what do they tell us?
The internationally renowned ITP expert faculty
- Dr Vickie McDonald: London, UK
- Prof. James Bussel: New York, NY, USA,
- Prof. Waleed Ghanima: Oslo, Norway
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/itp-eha-isth-2024/
102 episode
Manage episode 438235756 series 3389426
touchCONGRESS for touchONCOLOGY
Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Dr McDonald
- Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below
Clinical themes
- How does ITP impact the patient and their quality of life?
- What are the latest data that inform the use of current treatments for chronic ITP?
- What data are there for emerging chronic ITP treatments and what do they tell us?
The internationally renowned ITP expert faculty
- Dr Vickie McDonald: London, UK
- Prof. James Bussel: New York, NY, USA,
- Prof. Waleed Ghanima: Oslo, Norway
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/itp-eha-isth-2024/
102 episode
Semua episode
×1 Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY 37:37
1 Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY 37:38
1 Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting 38:15
1 Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY 34:20
1 Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY 34:19
1 Advances in IOL technology and power calculations: Updates and innovations from 2024 13:58
1 Supporting healing in epidermolysis bullosa: Innovations and new directions for care 18:55
1 Primary biliary cholangitis: Appraising the changing therapeutic landscape 35:31
1 Primary biliary cholangitis: Appraising the changing therapeutic landscape 35:31
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 13:46
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 16:05
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 13:46
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 16:05
1 touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? 15:14
1 touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? 13:57
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.